HUMAN PAPILLOMA VIRUS IMMUNOGEN CREATION ON THE BASE OF CHIMERIC RECOMBINANT PROTEIN L2E7
The cervical cancer is one of the most common diseases in world. This malignancy is the seventh highest prevalence oncological disease worldwide and the second highest prevalence oncological disease of women in the world. Meanwhile women need to be infected by human papilloma virus (HPV) is absolute...
Guardado en:
Autores principales: | I. S. Malakhov, R. I. Al-Shehadat, I. V. Duckhovlinov, A. S. Simbirtsev |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
Sankt-Peterburg : NIIÈM imeni Pastera
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7741ee2be8934944ab6d405110242e00 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
FREQUENCY OF HUMAN PAPILLOMA VIRUS IN IRKUTSK POPULATION
por: E. V. Belyaeva, et al.
Publicado: (2018) -
Genital warts trends in Australian and overseas-born people in Australia: A cross-sectional trend analysis to measure progress towards control and elimination
por: Laila Khawar, MPH, et al.
Publicado: (2021) -
Chimeric HBcAg virus-like particles presenting a HPV 16 E7 epitope significantly suppressed tumor progression through preventive or therapeutic immunization in a TC-1-grafted mouse model
por: Chu X, et al.
Publicado: (2016) -
VIRUS OF HUMAN PAPILLOMA. EPIDEMIOLOGY, LABORATORY DIAGNOSTICS AND PREVENTION OF PAPILLOMA VIRAL INFECTION
por: O. V. Narvskaya
Publicado: (2014) -
Self-Assembled Nanofibers Elicit Potent HPV16 E7-Specific Cellular Immunity And Abolish Established TC-1 Graft Tumor
por: Li S, et al.
Publicado: (2019)